Novavax, Inc. (NASDAQ:NVAX) traded at $16.41 at last check on Wednesday, July 24, made an upward move of 0.12% on its previous day’s price.
Looking at the stock we see that its previous close was $16.39 . In terms of its 52-week price range, NVAX has a high of $23.86 and a low of $3.53. The company’s stock has gained about 17.05% over that past 30 days.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Novavax, Inc. has a market cap of $2.30 billion. Estimates by analysts give the company expected earnings per share (EPS) of 1.36, with the EPS growth for the year raised at 0.48 for current year and 0.48 for next year.
According to analyst consensus estimates figures, the company’s yearly revenue forecast for current year is expected to hit 995.88M, or 1.20% up from figures reported last year.
Based on estimates by 15 analysts, where scores have ranged from 1.00 for a strong buy to 5.00 for a strong sell, 6 have rated the Novavax, Inc. (NVAX) stock as a Hold, while 9 rate it as a Buy. 0 analyst(s) rate it as overweight while 0 of them rated it as underweight, whereas 0 suggest the stock as a Sell. The stock has an overall rating of Buy and investors could take advantage and scoop up stock of the company.
Looking further, we note the current price level is 20.57% off its SMA20 and 12.77% from its 50-day simple moving average. The RSI (14) is pointing at 61.52 while the volatility over the past week is 10.32% and jumps to 7.89% over the past one month. The beta value is 1.98, while the average true range (ATR) is currently pointing at 1.29. The average price target for the stock over the next 12 months is $31, with the estimates having a low of $19 and a high of $174. These price ends are -15.78% and -960.33% off the today’s price level respectively, although investors could be excited at the prospect of a -88.91% if the NVAX share price touches on the median price of $31.
Coming back to Novavax, Inc. (NASDAQ:NVAX), we note that the average 3-month trading volume was 16.85 million, while that of the preceding 10-day period stands at 8.22 million. Current shares outstanding are 139.51 million.
The insiders hold 5.04% of the company’s shares while institutions hold 48.81%. The data shows that short shares as of 2024-06-28, stood at 29.53 million at a short ratio of 1.82. This represents a 25.5525.5525.5525.5525.5525.5525.5525.5525.5525.5525.5525.5525.5525.5525.5525.5525.5525.5525.5525.5525.5525.5525.5525.5525.5525.5525.5525.5525.5525.5525.5525.5525.5525.5525.5525.5525.5525.5525.5525.5525.5525.5525.5525.5525.5525.5525.5525.5525.5525.5525.5525.5525.5525.5525.5525.5525.5525.5525.5525.5525.5525.5525.5525.5525.5525.5525.5525.5525.5525.5525.5525.5525.5525.5525.5525.5525.5525.5525.5525.5525.5525.5525.5525.5525.5525.5525.5525.5525.5525.5525.5525.5525.5525.5525.5525.5525.5525.5525.5525.55 short interest in shares outstanding on 2024-06-28. Shares short fall in June from the previous month at 38.21 million. Investors should be excited about this stock as its upside potential is great, with today’s price pushing the stock 241.87% up in year-to-date price movement.
